학술논문

An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE).
Document Type
Article
Source
American Journal of Respiratory & Critical Care Medicine; 1/15/2023, Vol. 207 Issue 2, p138-149, 48p
Subject
CLINICAL trials
GALECTINS
COVID-19
PNEUMONIA
FLUTICASONE
ANALYSIS of covariance
Language
ISSN
1073449X
Abstract
Copyright of American Journal of Respiratory & Critical Care Medicine is the property of American Thoracic Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)